Home Therapeutic implications of brain steroidogenesis
Article
Licensed
Unlicensed Requires Authentication

Therapeutic implications of brain steroidogenesis

  • Iñigo Azcoitia , Lydia L. DonCarlos , Maria-Angeles Arevalo and Luis M. Garcia-Segura
Published/Copyright: August 11, 2009

Abstract

The nervous system is a steroidogenic tissue and several steroids synthesized locally in the brain, such as pregnenolone, progesterone and estradiol, modulate neuronal and glial physiology and are neuroprotective. The brain upregulates steroidogenesis at sites of injury as part of a program triggered by neural tissue to cope with neurodegenerative insults. Pharmacological targets to increase brain steroidogenesis and promote neuroprotection include the molecules that transport cholesterol to the inner mitochondrial membrane, where the first enzyme for steroidogenesis is located. Furthermore, the human gene encoding aromatase, the enzyme that synthesizes estradiol, is under the control of different tissue-specific promoters, and it is therefore conceivable that selective aromatase modulators can be developed that will enhance the expression of the enzyme and the consequent increase in estrogen formation in the brain but not in other tissues.


Corresponding author: Iñigo Azcoitia, Departamento de Biología Celular, Facultad de Biología, Universidad Complutense, E-28040 Madrid, Spain Phone: +34-913944861, Fax: +34-913944981,

Received: 2009-5-26
Accepted: 2009-6-16
Published Online: 2009-08-11
Published in Print: 2010-01-01

©2009 by Walter de Gruyter Berlin New York

Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/HMBCI.2010.003/html
Scroll to top button